| Copper | Approved Investigational | GNB4 | 59345 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GNB4 mRNA | 3q26.33 | |
| Copper | Approved Investigational | GNG2 | 54331 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GNG2 mRNA | 14q22.1 | |
| Copper | Approved Investigational | GOLGA8B | 440270 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GOLGA8B mRNA | 15q14 | |
| Copper | Approved Investigational | GOLT1B | 51026 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GOLT1B mRNA | 12p12.1 | |
| Copper | Approved Investigational | GOSR2 | 9570 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of GOSR2 mRNA | 17q21.32 | |
| Copper | Approved Investigational | GOSR2 | 9570 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GOSR2 mRNA | 17q21.32 | |
| Copper | Approved Investigational | GPCPD1 | 56261 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GPCPD1 mRNA | 20p12.3 | |
| Copper | Approved Investigational | GPM6B | 2824 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GPM6B mRNA | Xp22.2 | |
| Copper | Approved Investigational | GPNMB | 10457 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GPNMB mRNA | 7p15.3 | |
| Copper | Approved Investigational | GPR1 | 2825 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of GPR1 mRNA | 2q33.3 | |
| Copper | Approved Investigational | GPR161 | 23432 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GPR161 mRNA | 1q24.2 | |
| Copper | Approved Investigational | GPSM1 | 26086 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of GPSM1 mRNA | 9q34.3 | |
| Copper | Approved Investigational | GPSM2 | 29899 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GPSM2 mRNA | 1p13.3 | |
| Copper | Approved Investigational | GPT2 | 84706 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of GPT2 mRNA | 16q11.2 | |
| Copper | Approved Investigational | GRAMD1A | 57655 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of GRAMD1A mRNA | 19q13.11 | |
| Copper | Approved Investigational | GRAMD3 | 65983 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of GRAMD3 mRNA | 5q23.2 | |
| Copper | Approved Investigational | GRASP | 160622 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of GRASP mRNA | 12q13.13 | |
| Copper | Approved Investigational | GRB14 | 2888 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GRB14 mRNA | 2q24.3 | |
| Copper | Approved Investigational | GRHL1 | 29841 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GRHL1 mRNA | 2p25.1 | |
| Copper | Approved Investigational | GRSF1 | 2926 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GRSF1 mRNA | 4q13.3 | |
| Copper | Approved Investigational | GRWD1 | 83743 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of GRWD1 mRNA | 19q13.33 | |
| Copper | Approved Investigational | GSDMD | 79792 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GSDMD mRNA | 8q24.3 | |
| Copper | Approved Investigational | GSK3B | 2932 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GSK3B mRNA | 3q13.33 | |
| Copper | Approved Investigational | GSPT1 | 2935 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GSPT1 mRNA | 16p13.13 | |
| Copper | Approved Investigational | GSTA4 | 2941 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GSTA4 mRNA | 6p12.2 | |